These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 25591645)

  • 21. A prospective, randomized, placebo-controlled, double-blind trial about safety and efficacy of combined treatment with alteplase (rt-PA) and Cerebrolysin in acute ischaemic hemispheric stroke.
    Lang W; Stadler CH; Poljakovic Z; Fleet D;
    Int J Stroke; 2013 Feb; 8(2):95-104. PubMed ID: 23009193
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effect of cerebrolysin on the electroencephalographic indices of brain activity in Parkinson's disease].
    Lukhanina EP; Karaban' IN; Burenok IuA; Mel'nik NA; Berezetskaia NM
    Zh Nevrol Psikhiatr Im S S Korsakova; 2004; 104(7):54-60. PubMed ID: 15347036
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cerebrolysin in vascular dementia: improvement of clinical outcome in a randomized, double-blind, placebo-controlled multicenter trial.
    Guekht AB; Moessler H; Novak PH; Gusev EI;
    J Stroke Cerebrovasc Dis; 2011; 20(4):310-8. PubMed ID: 20656516
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The pathophysiological analysis of cerebrolysin therapy of children with mental developmental delay caused by ecological factors].
    Govorin NV; Zlova TP; Akhmetova VV; Tarasova OA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(5):51-5. PubMed ID: 18577958
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Electrophysiological correlates of efficacy of nootropic drugs in the treatment of consequences of traumatic brain injury in adolescents].
    Iznak EV; Iznak AF; Pankratova EA; Zavadenko NN; Guzilova LS; Guzilova IuI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(5 Pt 1):27-32. PubMed ID: 21322822
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The influence of cerebrolysin on the efficiency of subsequent therapy with amiridine++ in Alzheimer's disease patients (neuropsychological investigation)].
    Roshchina IF; Kolykhalov IV; Selezneva ND; Zharikov GA; Gerasimov NP; Gavrilova SI
    Zh Nevrol Psikhiatr Im S S Korsakova; 1999; 99(12):43-6. PubMed ID: 10629930
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [An effect of long-term cerebrolysin therapy in combination with neuroleptics on behavioral and cognitive disturbances in endogenous childhood autism].
    Radzivil MG; Bashina VM
    Zh Nevrol Psikhiatr Im S S Korsakova; 2006; 106(2):21-5. PubMed ID: 16548370
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Use of cerebrolysin in the treatment of prolonged extrapyramidal complications of neuroleptic therapy].
    Kontsevoĭ VA; Medvedev AV; Andrusenko MP; Zvenigorodskaia IuV; Sheshenin VS
    Zh Nevrol Psikhiatr Im S S Korsakova; 1997; 97(6):39-44. PubMed ID: 11517474
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cerebrolysin in Alzheimer's disease: a randomized, double-blind, placebo-controlled trial with a neurotrophic agent.
    Panisset M; Gauthier S; Moessler H; Windisch M;
    J Neural Transm (Vienna); 2002 Jul; 109(7-8):1089-104. PubMed ID: 12111446
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [An impact of neuroprotective therapy on blood rheological and morphodensitometric parameters in patients with chronic cerebral ischemia].
    Anisimova AV; Kolesnikova TI; Iutskova EV; Galkin SS; Zimin IA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2014; 114(10):72-80. PubMed ID: 25591521
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Current conceptions of neurocytoprotective therapy].
    Gomazkov OA; Afanas'ev VV; Rumiantseva SA; Stupin VA; Silina EV; Sokhova OA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(12 Pt 2):58-63. PubMed ID: 22792751
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safety and efficacy of Cerebrolysin in motor function recovery after stroke: a meta-analysis of the CARS trials.
    Guekht A; Vester J; Heiss WD; Gusev E; Hoemberg V; Rahlfs VW; Bajenaru O; Popescu BO; Doppler E; Winter S; Moessler H; Muresanu D
    Neurol Sci; 2017 Oct; 38(10):1761-1769. PubMed ID: 28707130
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The therapeutic potential of cerebrolysin in the preventive therapy of Alzheimer's disease].
    Gavrilova SI; Fedorova IaB; Kolykhalov IV; Odinak MM; Emelin AIu; Kashin AV; Selezneva ND; Kalyn IaB; Roshchina IF
    Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(8):24-8. PubMed ID: 18833104
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Spotlight on cerebrolysin in dementia.
    Plosker GL; Gauthier S
    CNS Drugs; 2010 Mar; 24(3):263-6. PubMed ID: 20155999
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Cerebrolysin for acute ischemic stroke].
    iganshina LE; Abakumova TR
    Vestn Ross Akad Med Nauk; 2013; (1):21-9. PubMed ID: 23805635
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The efficacy of combination therapy with mexidol and cerebrolysin in chronic cerebral ischemia].
    Berezhnaya SV; Yakupov EZ; Zaharov YA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(5):23-27. PubMed ID: 27240176
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Cerebrolysin treatment of mild cognitive impairment of vascular genesis].
    Damulin IV; Mkhitarian EA; Koberskaia NN
    Ter Arkh; 2007; 79(6):65-9. PubMed ID: 17684971
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety and efficacy of Cerebrolysin in acute brain injury and neurorecovery: CAPTAIN I-a randomized, placebo-controlled, double-blind, Asian-Pacific trial.
    Poon W; Matula C; Vos PE; Muresanu DF; von Steinbüchel N; von Wild K; Hömberg V; Wang E; Lee TMC; Strilciuc S; Vester JC
    Neurol Sci; 2020 Feb; 41(2):281-293. PubMed ID: 31494820
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cerebrolysin therapy in Rett syndrome: clinical and EEG mapping study.
    Gorbachevskaya N; Bashina V; Gratchev V; Iznak A
    Brain Dev; 2001 Dec; 23 Suppl 1():S90-3. PubMed ID: 11738849
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Therapeutic effects of cerebrolysin added to risperidone in patients with schizophrenia dominated by negative symptoms.
    Xiao S; Xue H; Li G; Yuan C; Li X; Chen C; Wu HZ; Mitchell P; Zhang M
    Aust N Z J Psychiatry; 2012 Feb; 46(2):153-60. PubMed ID: 22311531
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.